PIA
XBI icon

Petredis Investment Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Petredis Investment Advisors’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.53M Buy
53,888
+48
+0.1% +$6.49K 0.57% 38
2026
Q1 		$6.88M Sell
53,840
-390
-0.7% -$48.7K 0.56% 41
2025
Q4 		$6.61M Sell
54,230
-600
-1% -$68.8K 0.52% 41
2025
Q3 		$5.49M Sell
54,830
-340
-0.6% -$30.6K 0.44% 45
2025
Q2 		$4.58M Buy
55,170
+503
+0.9% +$40.1K 0.4% 56
2025
Q1 		$4.43M Buy
54,667
+1,018
+2% +$91K 0.46% 47
2024
Q4 		$4.83M Sell
53,649
-1,177
-2% -$114K 0.5% 42
2024
Q3 		$5.42M Buy
54,826
+122
+0.2% +$12K 0.58% 43
2024
Q2 		$5.07M Sell
54,704
-56
-0.1% -$5.02K 0.57% 44
2024
Q1 		$5.2M Buy
54,760
+1,336
+3% +$124K 0.62% 38
2023
Q4 		$4.77M Sell
53,424
-1,741
-3% -$129K 0.63% 39
2023
Q3 		$4.03M Buy
55,165
+72
+0.1% +$5.75K 0.57% 43
2023
Q2 		$4.58M Sell
55,093
-256
-0.5% -$21.4K 0.63% 40
2023
Q1 		$4.22M Buy
55,349
+708
+1% +$58.7K 0.66% 41
2022
Q4 		$4.54M Buy
+54,641
New +$4.42M 0.82% 35

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Petredis Investment Advisors's XBI Position: Q2 2026 in Review

Petredis Investment Advisors increased its State Street SPDR S&P Biotech ETF (XBI) stake by 0.09% in Q2 2026, buying an estimated $6.49K and bringing the position to 53,888 shares worth $8.53M. The position accounts for 0.57% of the portfolio, ranked #38.

Petredis Investment Advisors first reported a position in XBI in Q4 2022 and has held it in 15 quarters since. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Petredis Investment Advisors held 53,888 shares of State Street SPDR S&P Biotech ETF worth $8.53M as of Q2 2026.
  • Petredis Investment Advisors bought 48 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $6.49K.
  • State Street SPDR S&P Biotech ETF made up 0.57% of Petredis Investment Advisors's portfolio in Q2 2026, its #38 holding.
  • Petredis Investment Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2022 and has held it in 15 quarters since.
  • 932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Petredis Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.